000			02211 a2200625 4500
005			20250516141118.0
264		0	_c20130705
008			201307s 0 0 eng d
022			_a1879-0852
024	7		_a10.1016/j.ejca.2013.02.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aLevy, Antonin
245	0	0	_aSecond line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients. _h[electronic resource]
260			_bEuropean journal of cancer (Oxford, England : 1990) _cMay 2013
300			_a1898-904 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnalysis of Variance
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBevacizumab
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aCardiovascular Diseases _xchemically induced
650	0	4	_aDisease Progression
650	0	4	_aDrug Administration Schedule
650	0	4	_aEverolimus
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aIndoles _xadministration & dosage
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNiacinamide _xadministration & dosage
650	0	4	_aPhenylurea Compounds _xadministration & dosage
650	0	4	_aPyrroles _xadministration & dosage
650	0	4	_aSirolimus _xadministration & dosage
650	0	4	_aSorafenib
650	0	4	_aSunitinib
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aMenard, Jean
700	1		_aAlbiges, Laurence
700	1		_aLoriot, Yohann
700	1		_aDi Palma, Mario
700	1		_aFizazi, Karim
700	1		_aEscudier, Bernard
773	0		_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 49 _gno. 8 _gp. 1898-904
856	4	0	_uhttps://doi.org/10.1016/j.ejca.2013.02.003 _zAvailable from publisher's website
999			_c22581728 _d22581728